HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul Saftig Selected Research

Protein Isoforms (Isoforms)

1/2015LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease.
11/2005Unifying nomenclature for the isoforms of the lysosomal membrane protein LAMP-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul Saftig Research Topics

Disease

29Alzheimer Disease (Alzheimer's Disease)
04/2024 - 12/2003
13Neoplasms (Cancer)
01/2022 - 03/2004
12Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
12/2022 - 02/2007
11Inflammation (Inflammations)
01/2022 - 09/2006
9Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 06/2006
7Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2019 - 07/2005
7alpha-Mannosidosis
10/2017 - 09/2004
6Parkinson Disease (Parkinson's Disease)
01/2022 - 02/2009
5Amyloid Plaque
11/2021 - 02/2011
5Gaucher Disease (Gaucher's Disease)
10/2016 - 11/2007
5Bone Resorption
04/2013 - 09/2006
4Synucleinopathies
01/2022 - 02/2009
4Osteoporosis
05/2016 - 09/2008
4Infections
01/2016 - 02/2006
4Arthritis (Polyarthritis)
04/2013 - 02/2008
3Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2021 - 02/2015
3Dementia (Dementias)
10/2016 - 01/2008
3Fibrosis (Cirrhosis)
04/2015 - 06/2004
3Atherosclerosis
12/2013 - 09/2008
2Tauopathies
04/2024 - 10/2023
2Lymphopenia (Lymphocytopenia)
01/2023 - 07/2010
2Hypertrophy
01/2022 - 05/2007
2Retinal Degeneration
01/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2016
2Gliosis
10/2021 - 01/2021
2Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
09/2016 - 02/2010
2Atherosclerotic Plaque (Atheroma)
04/2015 - 09/2008
2Seizures (Absence Seizure)
08/2013 - 07/2010
2Obesity
04/2013 - 08/2007
2Colitis
04/2013 - 08/2010
2Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2012 - 12/2005
2Atrophy
02/2011 - 02/2003
2Mannosidase Deficiency Diseases (Mannosidosis)
01/2011 - 08/2006
2Skin Diseases (Skin Disease)
07/2008 - 05/2004
2Autoimmune Diseases (Autoimmune Disease)
02/2008 - 07/2004
2Starvation
09/2004 - 07/2004
1Lung Neoplasms (Lung Cancer)
10/2023

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2003
22Cathepsin DIBA
04/2024 - 02/2003
17Amyloid (Amyloid Fibrils)IBA
04/2024 - 12/2003
16Peptide Hydrolases (Proteases)FDA Link
04/2024 - 06/2005
14Amyloid Precursor Protein Secretases (beta-Secretase)IBA
05/2023 - 07/2004
13Metalloproteases (Metalloproteinases)IBA
05/2023 - 07/2006
13EnzymesIBA
01/2022 - 12/2004
12Cathepsin KIBA
05/2016 - 06/2004
9DisintegrinsIBA
05/2023 - 09/2006
7Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2024 - 01/2020
7Peptides (Polypeptides)IBA
01/2023 - 10/2006
7Lysosomal Membrane ProteinsIBA
10/2020 - 03/2003
7AcidsIBA
12/2017 - 09/2004
7alpha-Mannosidase (LAMAN)IBA
10/2017 - 09/2004
6Amyloid beta-PeptidesIBA
05/2023 - 12/2004
6Glucosylceramidase (Glucocerebrosidase)IBA
01/2022 - 11/2007
6Cysteine Proteases (Cysteine Protease)IBA
02/2015 - 09/2006
5LipidsIBA
01/2023 - 12/2005
5Retinaldehyde (Retinal)IBA
01/2022 - 02/2003
5Mannose (D-Mannose)IBA
01/2022 - 09/2004
4Cathepsin LIBA
01/2023 - 10/2011
4CytokinesIBA
12/2022 - 07/2008
4Prion ProteinsIBA
01/2022 - 02/2015
4SynucleinsIBA
01/2022 - 06/2011
4LigandsIBA
11/2021 - 03/2004
4Aspartic Acid ProteasesIBA
01/2021 - 12/2003
4CeroidIBA
01/2020 - 02/2007
4CholesterolIBA
08/2014 - 12/2005
3Cathepsin BIBA
01/2022 - 01/2020
3SaposinsIBA
01/2022 - 01/2020
3PrionsIBA
11/2021 - 01/2015
3HydrolasesIBA
01/2017 - 11/2015
3OligosaccharidesIBA
11/2015 - 09/2004
2sarkosylIBA
04/2024 - 10/2023
2SilverIBA
04/2024 - 10/2023
2Lysosomal-Associated Membrane Protein 2IBA
01/2023 - 01/2020
2ChemokinesIBA
12/2022 - 02/2011
2Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
01/2022 - 12/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2008
2Phosphates (Orthophosphate)IBA
01/2022 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2011
2IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
01/2022 - 11/2007
2Lysosomal-Associated Membrane Protein 1IBA
01/2022 - 01/2020
2Amino AcidsFDA Link
01/2022 - 07/2004
2Protein AggregatesIBA
10/2021 - 01/2020
2lysosomal proteinsIBA
01/2021 - 07/2008
2ProgranulinsIBA
10/2020 - 01/2017
2Lysergic Acid Diethylamide (LSD)IBA
01/2020 - 01/2019
2LipofuscinIBA
01/2020 - 09/2007
2GlycosaminoglycansIBA
12/2018 - 11/2009
2alpha-SynucleinIBA
10/2016 - 02/2009
2TetraspaninsIBA
01/2016 - 09/2013
2Cathepsin FIBA
02/2015 - 04/2013
2Protein Isoforms (Isoforms)IBA
01/2015 - 11/2005
2IgE Receptors (Fc epsilon RI)IBA
09/2013 - 12/2006
2Presenilin-1IBA
04/2012 - 11/2004
2GangliosidesIBA
01/2011 - 08/2008
2Apolipoproteins E (ApoE)IBA
03/2010 - 09/2008
2Virulence Factors (Pathogenicity Factors)IBA
01/2010 - 02/2006
2Cadherins (E-Cadherin)IBA
07/2008 - 05/2007
1Lamin Type A (Lamin A)IBA
10/2023

Therapy/Procedure

7Enzyme Replacement Therapy
01/2022 - 09/2004
6Therapeutics
01/2022 - 07/2006